A Study of LY3164530 in Participants With Cancer

Clinical trial NCT02221882 · COMPLETED

Trial details

NCT number: NCT02221882
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Neoplasms Neoplasm Metastasis

Start date: 2014-08-01
Primary completion: 2017-03-07
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.